axicabtagene ciloleucel
daiichi sankyo,gilead
['axi-cel', 'dlbcl', 'lymsm']
real world data comparing axi-cel to cit in &gt; 65 y old patients with r/r lbcl:
impressive results from #ash22 #lymsm 
Hem/Onc fellow @WeillCornell | #bmtsm #Celltherapy I share my tweets in @HematologyTweet